NVCN Projected Dividend Yield
Com No Par (New)/Neovasc Inc ( NASDAQ : NVCN )Neovasc is a medical device company that develops, manufactures and markets products for the cardiovascular marketplace. Its products include Neovasc Reducer™, which is a treatment for patients with refractory angina, a condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle, despite treatment with standard revascularization or cardiac drug therapies; and Tiara™, which is a product for treating mitral valve disease. 20 YEAR PERFORMANCE RESULTS |
NVCN Dividend History Detail NVCN Dividend News NVCN Competitors News |
Year | Declaration Date | Ex-Dividend Date | Record Date | Payable Date | Dividend $ Amount |
Total: | 0.0000 |